| Literature DB >> 30927119 |
Charlotte A Slade1,2,3, Catriona McLean4, Thomas Scerri5,6, Tran Binh Giang7,8,5, Steven Megaloudis7,8,5, Alexander Strathmore7,8,5, Jessica C Tempany8,5, Katherine Nicholls7, Colleen D'Arcy4, Melanie Bahlo5,6, Philip D Hodgkin8,5, Jo A Douglass7,9, Vanessa L Bryant7,8,5.
Abstract
Common variable immunodeficiency is the most prevalent of the primary immunodeficiency diseases, yet its pathogenesis is largely poorly understood. Of the cases that are monogenic, many arise due to pathogenic variants in NFKB1 and NFKB2. Here, we report enteroviral encephalomyelitis as the cause of a fatal neurodegenerative condition in a patient with a novel heterozygous mutation in NFKB2 (c.2543insG, p.P850Sfs36*) that disrupts non-canonical NF-κB signaling. Investigations of primary and secondary lymphoid tissue demonstrated a complete absence of B cells and germinal centers. Despite multiple negative viral PCR testing of cerebrospinal fluid during her disease progression, post-mortem analysis of cerebral tissue revealed a chronic lymphocytic meningoencephalitis, in the presence of Cocksackie A16 virus, as the cause of death. The clinical features, and progression of disease reported here, demonstrate divergent clinical and immunological phenotypes of individuals within a single family. This is the first reported case of fatal enteroviral encephalomyelitis in a patient with NF-κB2 deficiency and mandates a low threshold for early brain biopsy and the administration of increased immunoglobulin replacement in any patient with a defect in this pathway and deterioration of neurological status.Entities:
Keywords: CVID; Immunodeficiency; NF-kappaB2 deficiency; NFKB2; encephalitis; enterovirus
Mesh:
Substances:
Year: 2019 PMID: 30927119 DOI: 10.1007/s10875-019-00602-x
Source DB: PubMed Journal: J Clin Immunol ISSN: 0271-9142 Impact factor: 8.542